In a groundbreaking study published in the International Journal of Molecular Sciences; researchers unveil a promising therapeutic approach to PCOS Treatment. Polycystic Ovary Syndrome (PCOS) using mesenchymal stem cell-derived extracellular vesicles (EVs), commonly known as exosomes. PCOS is a hormonal disorder affecting women of reproductive age. It presents challenges in treatment due to diverse symptoms and complex underlying causes.
Previously identified as beneficial for PCOS symptoms, mesenchymal stem cells (MSCs) are known for their regenerative properties, and release therapeutic components clarified in the study as EVs. These EVs exhibit the ability to downregulate genes contributing to the overproduction of androgen hormones, a defining characteristic of PCOS.
The advantages of EV-based therapy over conventional methods are significant. Unlike whole stem cell therapy, EVs are more accessible and cost-effective, making them suitable for widespread applications. Additionally, concerns about tumorigenesis or immunogenicity are minimized, ensuring a safer treatment profile.
Clinical trials utilizing EV therapy for reproductive disorders have gained approval, indicating the potential for real-world benefits. The researchers highlight the role of IL-10, an immune signalling protein with anti-inflammatory properties, in the healing process. EVs may act as delivery vehicles, enhancing IL-10’s effectiveness in reducing inflammation and driving restorative processes.
Dr Park emphasizes the resilience of ovaries under EV treatment, offering renewed hope for women grappling with PCOS-related fertility issues. This research opens avenues for transformative therapies, addressing PCOS comprehensively and providing a ray of hope for those seeking effective, long-term solutions.
Courtesy Link (Rehash): https://www.indiatvnews.com/health/exosomes-stem-cell-derived-extracellular-vesicles-may-help-treat-pcos-2023-09-13-892527












